Abstract
Deaths from liver cancer are on the rise and disproportionately affect minority racial/ethnic groups. In this study, we examined associations between physicians’ recommendations for hepatitis B virus (HBV) and hepatitis C virus (HCV) screening and sociodemographic and lifestyle factors among minority populations in the areas of Greater Philadelphia and New York City. Using Poisson regression with robust variance estimation, we evaluated potential associations for 576 Hispanic American (HA), African American (AA), and Asian Pacific American (APA) adults, using blood tests as an outcome measure, with adjustment for sociodemographic factors We found that APAs (34.2%) were most likely to have a physician recommend HBV and HCV screening tests (34.2% and 27.1%, respectively), while HAs were least likely to receive an HBV recommendation (15.0%) and AAs were least likely to receive an HCV recommendation (15.3%). HAs were significantly likely to have never received a blood test for either HBV or HCV (RR = 1.25, 95% CI: 1.05, 1.49). APAs were significantly more likely to receive a screening recommendation for HBV (RR = 1.10, 95%CI: 1.01, 1.20) and to have a blood test (RR = 1.57, 95% CI: 1.06, 2.33). Our findings show that, among HAs, AAs, and APAs, physician recommendations are strongly associated with patients undergoing blood tests for HBV and HCV and that minority populations should increasingly be recommended to screen for HBV and HCV, especially given their elevated risk.
Similar content being viewed by others
References
Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69(1), 7–34. https://doi.org/10.3322/CAAC.21551
Viral Hepatitis and Liver Cancer (2016, March 1). Centers for Disease Control and Prevention.
Ringehan, M., McKeating, J. A., & Protzer, U. (2017). Viral hepatitis and liver cancer. Philosophical Transactions of the Royal Society B: Biological Sciences, 372(1732), 20160274. https://doi.org/10.1098/RSTB.2016.0274
Makarova-Rusher, O. V., Altekruse, S. F., McNeel, T. S., Ulahannan, S., Duffy, A. G., Graubard, B. I., & McGlynn, K. A. (2016). Population attributable fractions of risk factors for hepatocellular carcinoma in the United States. Cancer, 122(11), 1757–1765. https://doi.org/10.1002/CNCR.29971
Chang, E. T., Keegan, T. H. M., Gomez, S. L., Le, G. M., Clarke, C. A., So, S. K. S., & Glaser, S. L. (2007). The burden of Liver cancer in asians and Pacific islanders in the Greater San Francisco Bay area, 1990 through 2004. Cancer, 109(10), 2100–2108. https://doi.org/10.1002/CNCR.22642
Chen, M. S., & Dang, J. (2015). Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control. World Journal of Gastroenterology, 21(42), 11924. https://doi.org/10.3748/WJG.V21.I42.11924
El-Serag, H. B. (2012). Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142(6), 1264–1273.
El-Serag, H. B., Lau, M., Eschbach, K., Davila, J., & Goodwin, J. (2007). Epidemiology of hepatocellular carcinoma in hispanics in the United States. Archives of Internal Medicine, 167(18), 1983–1989. https://doi.org/10.1001/ARCHINTE.167.18.1983
Ajayi, F., Jan, J., Singal, A. G., & Rich, N. E. (2020). Racial and sex disparities in Hepatocellular Carcinoma in the USA. Current Hepatology Reports, 19(4), 462–469. https://doi.org/10.1007/S11901-020-00554-6
Islami, F., Miller, K. D., Siegel, R. L., Fedewa, S. A., Ward, E. M., & Jemal, A. (2017). Disparities in liver cancer occurrence in the United States by race/ethnicity and state. CA: A Cancer Journal for Clinicians, 67(4), 273–289. https://doi.org/10.3322/CAAC.21402
Litaker, J. R., Tamez, N., Lopez Bray, C., Allison, R. D., Durkalski, W., & Taylor, R. (2021). Hepatitis C antibody screening among baby boomers by a community-based health insurance company. Population Health Management, 24(4), 492. https://doi.org/10.1089/POP.2020.0214
Testing Recommendations for Hepatitis C Virus Infection | CDC. (n.d.). Retrieved January 22 (2023). from https://www.cdc.gov/hepatitis/hcv/guidelinesc.htm.
Weng, M. K., Doshani, M., Khan, M. A., Frey, S., Ault, K., Moore, K. L., & Nelson, N. P. (2022). Universal Hepatitis B vaccination in adults aged 19–59 Years: Updated recommendations of the advisory committee on immunization practices — United States, 2022. Morbidity and Mortality Weekly Report, 71(13), 477–483. https://doi.org/10.15585/MMWR.MM7113A1
Kardashian, A., Serper, M., Terrault, N., & Nephew, L. D. (2022). Health disparities in chronic Liver Disease. Hepatology, 00, 1–22. https://doi.org/10.1002/HEP.32743
Chu, J. N., Nguyen, T. T., Rivadeneira, N. A., Hiatt, R. A., & Sarkar, U. (2022). Exploring factors associated with Hepatitis B screening in a multilingual and diverse population. BMC Health Services Research, 22(1), 479. https://doi.org/10.1186/S12913-022-07813-W
Tohme, R. A., Xing, J., Liao, Y., & Holmberg, S. D. (2013). Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009–2010. American Journal of Public Health, 103(1), 112–119. https://doi.org/10.2105/AJPH.2012.300858
Caskey, R., Lindau, S. T., & Alexander, G. C. (2009). Knowledge and early adoption of the HPV Vaccine among girls and young women: Results of a National survey. Journal of Adolescent Health, 45(5), 453–462. https://doi.org/10.1016/J.JADOHEALTH.2009.04.021
Finney Rutten, L. J., Nelson, D. E., & Meissner, H. I. (2004). Examination of population-wide trends in barriers to cancer screening from a diffusion of innovation perspective (1987–2000). Preventive Medicine, 38(3), 258–268. https://doi.org/10.1016/J.YPMED.2003.10.011
NCA - Screening for Hepatitis C Virus (HCV) in Adults (CAG-00436 N) - Decision Memo. (n.d.). Retrieved November 6 (2022). from https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&NCAId=272
Zhu, L., Kim, E. J., González, E., Fraser, M. A., Zhu, S., Rubio-Torio, N., & Tan, Y. (2022). Reducing liver cancer risk through dietary change: Positive results from a community-based educational initiative in three racial/ethnic groups. Nutrients, 14(22), 4878. https://doi.org/10.3390/NU14224878
Holahan, C. J., Holahan, C. K., & Moos, R. H. (2022). Binge drinking and alcohol problems among Moderate Average-Level drinkers. American Journal of Preventive Medicine. https://doi.org/10.1016/J.AMEPRE.2022.03.021
Zou, G. (2004). A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwh090
El-Serag, H. B., & Mason, A. C. (2000). Risk factors for the rising rates of primary liver cancer in the United States. Archives of Internal Medicine, 160(21), 3227–3230. https://doi.org/10.1001/ARCHINTE.160.21.3227
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004). Primary liver cancer: Worldwide incidence and trends. Gastroenterology, 127(5), S5–S16. https://doi.org/10.1053/J.GASTRO.2004.09.011
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K. H., Elsharkawy, A. M., & Karin, M. (2007). Gender disparity in Liver cancer due to sex differences in MyD88-dependent IL-6 production. Science, 317(5834), 121–124. https://doi.org/10.1126/SCIENCE.1140485/SUPPL_FILE/NAUGLER.SOM.PDF
de Maria, N., Manno, M., & Villa, E. (2002). Sex hormones and liver cancer. Molecular and Cellular Endocrinology, 193(1–2), 59–63. https://doi.org/10.1016/S0303-7207(02)00096-5
Li, L., & Yeo, W. (2017). Value of quality of life analysis in liver cancer: A clinician’s perspective. World Journal of Hepatology, 9(20), 867. https://doi.org/10.4254/WJH.V9.I20.867
Lee, Y. C. A., Cohet, C., Yang, Y. C., Stayner, L., Hashibe, M., & Straif, K. (2009). Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. International Journal of Epidemiology, 38(6), 1497–1511. https://doi.org/10.1093/IJE/DYP280
Arem, H., Loftfield, E., Saint-Maurice, P. F., Freedman, N. D., & Matthews, C. E. (2018). Physical activity across the lifespan and liver cancer incidence in the NIH-AARP diet and health study cohort. Cancer Medicine, 7(4), 1450–1457. https://doi.org/10.1002/CAM4.1343
Turati, F., Galeone, C., Rota, M., Pelucchi, C., Negri, E., Bagnardi, V., & la Vecchia, C. (2014). Alcohol and liver cancer: A systematic review and meta-analysis ofprospective studies. Annals of Oncology, 25(8), 1526–1535. https://doi.org/10.1093/ANNONC/MDU020
Bockmann, J. H., Kohsar, M., Murray, J. M., Hamed, V., Dandri, M., Lüth, S., & Schulze-Zur-wiesch, J. (2021). High rates of liver cirrhosis and hepatocellular carcinoma in chronic Hepatitis B patients with metabolic and cardiovascular comorbidities. Microorganisms, 9(5), 968. https://doi.org/10.3390/MICROORGANISMS9050968
Le, M. H., Yeo, Y. H., Cheung, R., Henry, L., Lok, A. S., & Nguyen, M. H. (2020). Chronic Hepatitis B Prevalence Among Foreign-Born and US Born Adults in the United States, 1999–2016. Hepatology, 71(2), 431–443. https://doi.org/10.1002/HEP.30831
Fact sheet: Biden-Harris Administration Advances Equity and Opportunity for Asian American, Native Hawaiian, and Pacific Islander Communities Across the Country - The White House. (n.d.). Retrieved September 25 (2022). from https://www.whitehouse.gov/briefing-room/statements-releases/2022/01/20/fact-sheet-biden-harris-administration-advances-equity-and-opportunity-for-asian-american-native-hawaiian-and-pacific-islander-communities-across-the-country/.
Philbin, M. M., Erby, L. A. H., Lee, S., & Juon, H. S. (2012). Hepatitis B and Liver cancer among three Asian American sub-groups: A focus group inquiry. Journal of Immigrant and Minority Health, 14(5), 858–868. https://doi.org/10.1007/S10903-011-9523-0/TABLES/2
Asian Americans and their origins: Key facts | Pew Research Center. (n.d.). Retrieved September 25 (2022). from https://www.pewresearch.org/fact-tank/2021/04/29/key-facts-about-asian-origin-groups-in-the-u-s/.
Strong, C., Lee, S., Tanaka, M., & Juon, H. S. (2012). Ethnic differences in prevalence and barriers of HBV screening and vaccination among Asian americans. Journal of Community Health, 37(5), 1071–1080. https://doi.org/10.1007/S10900-012-9541-4/TABLES/5
Lavanchy, D. (2009). The global burden of hepatitis C. Liver International, 29, 74–81. https://doi.org/10.1111/J.1478-3231.2008.01934.X
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., & Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England journal of medicine, 341(8), 556–562. https://doi.org/10.1056/NEJM199908193410802
Wilder, J., Saraswathula, A., Hasselblad, V., & Muir, A. (2016). A systematic review of race and ethnicity in Hepatitis C clinical trial enrollment. Journal of the National Medical Association, 108(1), 24–29. https://doi.org/10.1016/J.JNMA.2015.12.004
McQuillan, G. M., Kruszon-Moran, D., Kottiri, B. J., Curtin, L. R., Lucas, J. W., & Kington, R. S. (2004). Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: Data from NHANES III, 1988–1994. American Journal of Public Health, 94(11), 1952. https://doi.org/10.2105/AJPH.94.11.1952
Pearlman, B. L. (2006). Hepatitis C virus infection in African americans. Clinical Infectious Diseases, 42(1), 82–91. https://doi.org/10.1086/498512
One-in-Ten Black People Living in the U.S. Are Immigrants | Pew Research Center. (n.d.). Retrieved November 7 (2022). from https://www.pewresearch.org/race-ethnicity/2022/01/20/one-in-ten-black-people-living-in-the-u-s-are-immigrants/.
Hassan, M. A., Kim, W. R., Li, R., Smith, C. I., Fried, M. W., Sterling, R. K., & Lok, A. S. F. (2017). Characteristics of US-Born versus foreign-born Americans of African descent with chronic hepatitis B. American Journal of Epidemiology, 186(3), 356. https://doi.org/10.1093/AJE/KWX064
Pomenti, S., Gandle, C., Abu Sbeih, H., Phipps, M., Livanos, A., Guo, A., & Wattacheril, J. (2020). Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort. Hepatology Communications, 4(11), 1708–1716. https://doi.org/10.1002/HEP4.1575
Ha, J., Yan, M., Aguilar, M., Tana, M., Liu, B., Frenette, C. T., & Wong, R. J. (2016). Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma stage at diagnosis and its impact on receipt of curative therapies. Journal of Clinical Gastroenterology, 50(5), 423–430. https://doi.org/10.1097/MCG.0000000000000448
Hu, D. J., Xing, J., Tohme, R. A., Liao, Y., Pollack, H., Ward, J. W., & Holmberg, S. D. (2013). Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009–2010. Hepatology, 58(3), 856–862. https://doi.org/10.1002/HEP.26286
Bindman, A. B., Grumbach, K., Osmond, D., Vranizan, K., & Stewart, A. L. (1996). Primary care and receipt of preventive services. Journal of General Internal Medicine, 11(5), 269–276. https://doi.org/10.1007/BF02598266
Frrante, J. M., Winston, D. G., Chen, P. H., & de la Torre, A. N. (2008). Family physicians’ knowledge and screening of chronic hepatitis and liver cancer - PubMed. Family Medicine, 40(5), 345–351. Retrieved from https://pubmed.ncbi.nlm.nih.gov/18465284/.
Chao, S. D., Wang, B. M., Chang, E. T., Ma, L., & So, S. K. (2015). Medical training fails to prepare providers to care for patients with chronic hepatitis B Infection. World Journal of Gastroenterology: WJG, 21(22), 6914. https://doi.org/10.3748/WJG.V21.I22.6914
Hwang, J. P., Roundtree, A. K., Engebretson, J. C., & Suarez-Almazor, M. E. (2010). Medical care of Hepatitis B among Asian American populations: Perspectives from three provider groups. Journal of General Internal Medicine, 25(3), 220–227. https://doi.org/10.1007/S11606-009-1204-5/FIGURES/1
Foster, T., Hon, H., Kanwal, F., Han, S., & Spiegel, B. (2011). Screening high risk individuals for hepatitis B: Physician knowledge, attitudes, and beliefs. Digestive Diseases and Sciences, 56(12), 3471–3487. https://doi.org/10.1007/S10620-011-1928-Z/TABLES/4
Tenner, C. T., Herzog, K., Chaudhari, S., Bini, E. J., & Weinshel, E. H. (2012). Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic Hepatitis C virus Infection: A survey of family medicine and internal medicine physicians in the United States. International Journal of Clinical Practice, 66(10), 1009–1013. https://doi.org/10.1111/IJCP.12013
Wu, Y., Johnson, K. B., Roccaro, G., Lopez, J., Zheng, H., Muiru, A., & Chung, R. T. (2014). Poor adherence to AASLD guidelines for chronic hepatitis B management and treatment in a large academic medical center. The American Journal of Gastroenterology, 109(6), 867. https://doi.org/10.1038/AJG.2014.72
Nguyen, T. T., McPhee, S. J., Stewart, S., Gildengorin, G., Zhang, L., Wong, C., & Chen, M. S. (2010). Factors associated with hepatitis B testing among Vietnamese Americans. Journal of General Internal Medicine, 25(7), 694–700. https://doi.org/10.1007/S11606-010-1285-1/TABLES/3
Toyoda, H., Huang, D. Q., Le, M. H., & Nguyen, M. H. (2020). Liver Care and Surveillance: The Global Impact of the COVID-19 pandemic. Hepatology Communications, 4(12), 1751–1757. https://doi.org/10.1002/HEP4.1579
Cheung, K. L., ten Klooster, P. M., Smit, C., de Vries, H., & Pieterse, M. E. (2017). The impact of non-response bias due to sampling in public health studies: A comparison of voluntary versus mandatory recruitment in a Dutch national survey on adolescent health. BMC Public Health, 17(1), 1–10. https://doi.org/10.1186/S12889-017-4189-8/TABLES/2
Acknowledgements
This study was supported by TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership, Award Number U54 CA221704(5) (Contact PIs: GX Ma, J Erblich) from the National Cancer Institute of National Institutes of Health (NCI/NIH) and by NIGMS/NIH award # 1SC3GM131949-01 (PI: MC Yeh). The author team would like to thank Community Advisory Board members, leaders, and staff members for collaborating with community/faith-based organization partners. We also acknowledge the research team staff of Planning Evaluation Core under TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership for their support and contribution for their support and contributions to Community Outreach Core’s data management. Its contents are solely the authors’ responsibility and do not necessarily represent the official views of the NCI/NIH or the NIGMS/NIH.
Funding
This study was supported by TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership, Award Number U54 CA221704(5) (Contact PIs: GX Ma, J Erblich) from the National Cancer Institute of National Institutes of Health (NCI/NIH) and by NIGMS/NIH award # 1SC3GM131949-01 (PI: MC Yeh).
Author information
Authors and Affiliations
Contributions
Conceptualization, MCY, GM; Methodology, MCY, GM, YT; Formal analysis, TB, VP; Investigation, MCY, GM, YT, SZ, NRT, HP, EG, MF; Resources, MCY, GM; Data curation, SZ, NRT, HP, EG, MF, YT; Writing—original draft preparation, TB; Writing—review and editing, TB, VP, LZ, YT; Supervision, MCY, GM, YT; Project administration, GM, YT, SZ, NRT, EG, MF; Funding acquisition, MCY, GM. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical Approval
The study was approved by Institutional Review Boards at Temple University and Hunter College.
Consent to Participate
All participants provided informed consent.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Begum, T.F., Patil, V.S., Zhu, L. et al. Assessing Physicians’ Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City. J Community Health (2024). https://doi.org/10.1007/s10900-023-01316-3
Accepted:
Published:
DOI: https://doi.org/10.1007/s10900-023-01316-3